Epigenetic targeting of Waldenström macroglobulinemia cells with BET inhibitors synergizes with BCL2 or histone deacetylase inhibition.
使用 BET 抑制剂对 Waldenström 巨球蛋白血症细胞进行表观遗传靶向治疗，可与 BCL2 或组蛋白去乙酰化酶抑制产生协同作用
期刊:Epigenomics
影响因子:2.6
doi:10.2217/epi-2020-0189
Matissek Stephan J, Han Weiguo, Karbalivand Mona, Sayed Mohamed, Reilly Brendan M, Mallat Shayna, Ghazal Shimaa M, Munshi Manit, Yang Guang, Treon Steven P, Walker Sarah R, Elsawa Sherine F
